Aytu BioPharma Inc.

AYTU | NASDAQ

Price Alert Chart Builder DCF Calculator

$2.12

$0 (0.00%)

At close: Sep 21, 2026, 4:00 PM ET

$2.19

+$0.07 (+3.30%)

After-hours: Sep 21, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $22.75M

Enterprise Value $-2.05M

Beta 0.27

Average Volume 33.73K

Shares Outstanding (Diluted) 10.51M

Shares Change YoY 28.12%

Institutional Ownership 37.60%

Exchange NASDAQ

ISIN US0547548588

Price Performance

Price Change 1M -9.8%

Price Change 3M -5.8%

Price Change 6M -22.1%

Price Change YTD -23.5%

Price Change 1Y -14.9%

Price Change 3Y 36.8%

Price Change 5Y -96.4%

1M CAGR (ann.) -9.0%

1Y CAGR (ann.) -8.6%

5Y CAGR (ann.) -49.7%

All-Time CAGR -55.0%

Valuation

PE Ratio -0.46

Forward PE 117.50

PEG Ratio 0.00

Forward PEG 0.00

PS Ratio 0.40

Forward PS 0.30

PB Ratio 0.65

P/FCF Ratio 13.87

P/Adj. FCF Ratio 18.29

P/OCF Ratio 13.25

EV/Sales -0.04

EV/EBIT 0.07

EV/EBITDA 0.08

EV/FCF -1.25

Earnings Yield -216.0%

FCF Yield 7.2%

Adj. FCF Yield 5.5%

Financial Health

Net Cash $15.31M

Total Debt $1.86M

Cash & Short-Term Investments $26.72M

Total Assets $111.69M

Current Ratio 1.12

Quick Ratio 1.00

Debt / Equity Ratio 0.65

Debt / EBITDA -0.07

Debt / FCF 1.13

OCF / Debt 0.90

Interest Coverage -6.76

Altman Z-Score -4.49

Piotroski F-Score 3

Margins & Profitability

Gross Profit Margin 62.5%

Operating Profit Margin -26.8%

EBITDA Margin -48.3%

Net Profit Margin -60.2%

FCF Margin 2.9%

Adj. FCF Margin 2.2%

SBC / Revenue 1.0%

SBC Impact (per share) -24.1%

Returns

Return on Assets -30.5%

Return on Equity -148.9%

Return on Invested Capital -23.6%

Return on Capital Employed -29.3%

Return on Tangible Assets -49.2%

Historical Growth (CAGR)

Revenue CAGR 3Y -18.4%

Revenue CAGR 5Y -0.1%

Revenue CAGR 10Y 41.1%

EPS CAGR 3Y -36.9%

EPS CAGR 5Y 96.2%

EPS CAGR 10Y 53.9%

FCF CAGR 3Y -246.1%

FCF CAGR 5Y 82.7%

FCF CAGR 10Y 14.5%

Analyst Forecasts

Analyst Rating Buy

Analyst Count 2

EPS Growth Next 3Y N/A

Revenue Growth Next 3Y N/A

Earnings Date N/A

EPS Estimate (next Q) N/A

EPS Growth Est (next Q) N/A

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $10.75

Price Target Upside 407.1%

Cash Flow

Operating Cash Flow $1.68M

Free Cash Flow $1.64M

Adj. Free Cash Flow $1.25M

FCF Per Share $0.16

OCF Per Share $0.16

OCF/S Ratio 3.0%

Income Statement

Revenue $56.6M

Gross Profit $35.38M

Operating Income $-15.16M

EBITDA $-26.22M

Net Income $-34.06M

EPS (Diluted) -$4.58

Revenue / Employee $681.92K

Profit / Employee $-410.3K

Employees 83